Kilitch Drugs (India) Limited — ≥1% Shareholders
Every non-promoter shareholder owning 1% or more of Kilitch Drugs (India) Limited, parsed from the latest quarterly Shareholding Pattern filing. Curated holders link to a tracked profile; mystery holders are flagged.
1 curated
7 mystery
Quarter: Mar 2026
Institutional intelligence for Kilitch Drugs (India) Limited
Cross-view mutual fund activity and super-investor shareholding · Mar 2026 SHP.
Tracked super investors holding ≥1%
| Holder | Type | % of company | Shares | Value (₹ Cr) |
|---|---|---|---|---|
| Kilitch Company (Pharma) Limited | dii | 37.92% | 1,32,58,684 | ₹165.0 Cr |
| Bhavin Mukund Mehta | individual | 14.43% | 50,46,276 | ₹62.8 Cr |
| Mukund Mehta | individual | 6.61% | 23,09,294 | ₹28.7 Cr |
| Mira Bhavin Mehta | individual | 4.81% | 16,82,092 | ₹20.9 Cr |
| Dipak Kanayalal Shah | individual | 3.64% | 12,72,500 | ₹15.8 Cr |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | dii | 2.30% | 8,04,196 | ₹10.0 Cr |
| Mukul Mahavir Agrawal | individual | 1.34% | 4,70,000 | ₹5.8 Cr |
| Premilaben Rameshchandra Shah | individual | 1.14% | 4,00,000 | ₹5.0 Cr |
Shareholding data sourced from NSE/BSE regulatory filings. Not investment advice. See our disclaimer and methodology.